Clinical evaluation of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome
Modi MB, Donga SB, Dei L
Ayu · 9 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (clasificado por nuestro filtro de IA)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2012-01-01 · Ayu · vol. 33 · número 4 · pág. 511
- Editorial
- Medknow
- Citado
- 34 citas · más que el 85% de estudios similares · 0.9× el promedio de su campo
- Referencias
- 11 trabajos
- Acceso
- Acceso abierto (copia en repositorio) · CC-BY-NC-SA
- Áreas de investigación
- Phytochemicals and Medicinal Plants · Menopause: Health Impacts and Treatments · Pharmacological Effects of Medicinal Plants
- Palabras clave
- Menopause, Medicine, Rating scale, Quality of life (healthcare), Physical therapy, Clinical trial, Wilcoxon signed-rank test, Randomized controlled trial, Gynecology, Internal medicine, Mann–Whitney U test, Psychology
3 autores
- MansiB Modi · autor de correspondencia
- ShilpaB Donga🇮🇳Gujarat Ayurved University
- Laxmipriya Dei🇮🇳Gujarat Ayurved University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Menopause is a gradual and natural transitional phase of adjustment between the active and inactive ovarian function and occupies several years of a women's life and involves biological and psychological changes adjustments. The present clinical trial was designed as per Ayurveda clinical trials protocol to evaluate the efficacy of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome. It was directed by Central Council for Research in Ayurvedic Sciences as randomized open clinical trial. Total 52 patients were registered in the study, out of which 51 patients completed the study. Specialized rating scales like Kupperman Index Score as well as Menopause Rating Scale (MRS) and Menopause Specific Quality of Life (MENQOL) questionnaires were adopted for diagnostic as well as assessment criteria. The effects were examined based on MRS and MENQOL. Results were analyzed statistically using Wilcoxon matched paired test and 't' test. Highly significant (P < 0.01) reduction was found in the symptoms of MRS as well as MENQOL. Finally, it can be stated that combined treatment of above drugs gives better result in both somatic as well as psychological complaints in women with mild to moderate symptoms of menopausal syndrome.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-SA).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.